Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients

Author： Bensmane M.A.   de Gramont A.   Brienza S.   Marty M.   Levi F.   Ducreux M.   Francois E.   Gamelin E.   Bleiberg H.   Bleuzen P.   Simon J.   Cvitkovic E.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.36, Iss.18, 2000-12, pp. : 2335-2343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5–16) in advanced colorectal cancer patients

By Terzoli Edmondo   Garufi Carlo   Zappalà Albina   Vanni Barbara   Pugliese Patrizia   Cappellini Giancarlo   Aschelter Anna   Perrone Maria   Giannarelli Diana  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 8, 2004-08 ,pp. : 445-452

Springer Publishing Company

Access to resources Recommend Favorite

High Dose 5-Fluorouracil (5-FU) and Folinic Acid in Advanced Colorectal Cancer Resistant to Standard Dose 5-FU Treatment: Results of a Phase II Study

By Jager E.   Klein O.   Wachter B.   Muller B.   Braun U.   Knuth A.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1717-1717

Elsevier

Access to resources Recommend Favorite

Plasma and Salivary Pharmacokinetics of 5-Fluorouracil (5-FU) in Patients with Metastatic Colorectal Cancer Receiving 5-FU Bolus Plus Continuous Infusion with High-dose Folinic Acid

By Joulia J.M.   Pinguet F.   Ychou M.   Duffour J.   Astre C.   Bressolle F.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 296-301

Elsevier

Access to resources Recommend Favorite

Doxifluridine in Colorectal Cancer Patients Resistant to 5-Fluorouracil (5-FU) Containing Regimens

By Bajetta E.   Di Bartolomeo M.   Somma L.   Del Vecchio M.   Artale S.   Zunino F.   Bignami P.   Magnani E.   Buzzoni R.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 687-690

Elsevier

Access to resources Recommend Favorite

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

By Van Cutsem E.   Cunningham D.   Ten Bokkel Huinink W.W.   Punt C.J.A.   Alexopoulos C.G.   Dirix L.   Symann M.   Blijham G.H.   Cholet P.   Fillet G.   Van Groeningen C.   Vannetzel J.M.   Levi F.   Panagos G.   Unger C.   Wils J.   Cote C.   Blanc C.   Herait P.   Bleiberg H.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 54-59

Elsevier

Access to resources Recommend Favorite